documents: FDA-2017-D-6564-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2017-D-6564-0001 | FDA | FDA-2017-D-6564 | Best Practices for Communication Between Investigational New Drug Application Sponsors and the Food and Drug Administration; Guidance for Industry and Review Staff; Availability | Notice | Notice of Availability | 2017-12-29T05:00:00Z | 2017 | 12 | 2017-12-29T05:00:00Z | 2017-12-29T14:28:34Z | 2017-28139 | 0 | 0 | 0900006482d832c0 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref